Bio-Thera Solutions Ltd (688177) - Net Assets

Latest as of March 2026: CN¥224.12 Million CNY ≈ $32.80 Million USD

Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has net assets worth CN¥224.12 Million CNY (≈ $32.80 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.39 Billion ≈ $349.02 Million USD) and total liabilities (CN¥2.16 Billion ≈ $316.22 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Bio-Thera Solutions Ltd to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥224.12 Million
% of Total Assets	9.4%
Annual Growth Rate	-3.83%
5-Year Change	-81.99%
10-Year Change	N/A
Growth Volatility	87.23

Bio-Thera Solutions Ltd - Net Assets Trend (2016–2025)

This chart illustrates how Bio-Thera Solutions Ltd's net assets have evolved over time, based on quarterly financial data. See Bio-Thera Solutions Ltd (688177) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Bio-Thera Solutions Ltd (2016–2025)

The table below shows the annual net assets of Bio-Thera Solutions Ltd from 2016 to 2025. For live valuation and market cap data, see Bio-Thera Solutions Ltd stock valuation.

Year	Net Assets	Change
2025-12-31	CN¥376.03 Million ≈ $55.03 Million	-46.89%
2024-12-31	CN¥708.09 Million ≈ $103.62 Million	-41.61%
2023-12-31	CN¥1.21 Billion ≈ $177.46 Million	-24.55%
2022-12-31	CN¥1.61 Billion ≈ $235.19 Million	-23.01%
2021-12-31	CN¥2.09 Billion ≈ $305.47 Million	+4.08%
2020-12-31	CN¥2.01 Billion ≈ $293.48 Million	+218.01%
2019-12-31	CN¥630.67 Million ≈ $92.29 Million	-21.30%
2018-12-31	CN¥801.32 Million ≈ $117.26 Million	+130.56%
2017-12-31	CN¥347.55 Million ≈ $50.86 Million	-34.97%
2016-12-31	CN¥534.43 Million ≈ $78.20 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Bio-Thera Solutions Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 282819529607.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Components	CN¥3.47 Billion	922.35%
Total Equity	CN¥376.03 Million	100.00%

Bio-Thera Solutions Ltd Competitors by Market Cap

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their market capitalization.

Company	Market Cap
Tianjin Ringpu Bio Tech SHE:300119	$1.03 Billion
Zhejiang Guyuelongshan Shaoxing Wine Co Ltd SHG:600059	$1.03 Billion
Bangkok Chain Hospital Public Company Limited BK:BCH-R	$1.03 Billion
Sunflower Pharmaceuticals Group Co Ltd SHE:002737	$1.03 Billion
Jiangsu Yinhe Electronics Co Ltd SHE:002519	$1.03 Billion
Shunfa Hengye Corp SHE:000631	$1.03 Billion
Hbt Financial Inc NASDAQ:HBT	$1.03 Billion
Inner Mongolia ERDOS Resources Co Ltd B SHG:900936	$1.03 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Bio-Thera Solutions Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 708,089,002 to 376,030,903, a change of -332,058,099 (-46.9%).
Net loss of 331,940,824 reduced equity.
Dividend payments of 20,392,769 reduced retained earnings.
Other factors increased equity by 20,275,494.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥-331.94 Million	-88.27%
Dividends Paid	CN¥20.39 Million	-5.42%
Other Changes	CN¥20.28 Million	+5.39%
Total Change	CN¥-	-46.89%

Book Value vs Market Value Analysis

This analysis compares Bio-Thera Solutions Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 18.79x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 17.38x to 18.79x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	CN¥0.98	CN¥17.06	x
2018-12-31	CN¥2.26	CN¥17.06	x
2019-12-31	CN¥1.78	CN¥17.06	x
2020-12-31	CN¥4.84	CN¥17.06	x
2021-12-31	CN¥5.04	CN¥17.06	x
2022-12-31	CN¥3.88	CN¥17.06	x
2023-12-31	CN¥2.93	CN¥17.06	x
2024-12-31	CN¥1.71	CN¥17.06	x
2025-12-31	CN¥0.91	CN¥17.06	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Bio-Thera Solutions Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -88.27%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -35.49%
• Asset Turnover: 0.41x
• Equity Multiplier: 6.08x
Recent ROE (-88.27%) is below the historical average (-56.89%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2016	-25.56%	-4942.14%	0.00x	1.33x	CN¥-190.03 Million
2017	-67.76%	-11723.31%	0.00x	1.78x	CN¥-270.26 Million
2018	-69.02%	0.00%	0.00x	1.27x	CN¥-633.24 Million
2019	-162.15%	-146088.83%	0.00x	1.61x	CN¥-1.09 Billion
2020	-25.59%	-277.43%	0.08x	1.19x	CN¥-713.79 Million
2021	3.93%	9.79%	0.32x	1.25x	CN¥-126.81 Million
2022	-29.89%	-105.55%	0.21x	1.36x	CN¥-641.12 Million
2023	-32.53%	-55.98%	0.31x	1.89x	CN¥-515.80 Million
2024	-72.07%	-68.67%	0.34x	3.11x	CN¥-581.11 Million
2025	-88.27%	-35.49%	0.41x	6.08x	CN¥-369.54 Million

Industry Comparison

This section compares Bio-Thera Solutions Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $604,930,526
Average return on equity (ROE) among peers: 13.07%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Bio-Thera Solutions Ltd (688177)	CN¥224.12 Million	-25.56%	9.64x	$1.03 Billion
Shenzhen CAU Technology Co Ltd (000004)	$85.02 Million	26.56%	2.79x	$53.47 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403)	$64.35 Million	12.98%	2.10x	$1.50 Billion
Nanhua Bio Medicine Co Ltd (000504)	$128.43 Million	-28.90%	2.15x	$378.62 Million
Jiangsu Sihuan Bioengineering Co Ltd (000518)	$730.78 Million	-9.68%	0.13x	$470.05 Million
Chengzhi Shareholding Co Ltd (000990)	$1.65 Billion	1.65%	0.84x	$1.54 Billion
Hualan Biological EngineeringInc (002007)	$94.10 Million	30.66%	1.57x	$3.43 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030)	$626.21 Million	14.40%	0.46x	$1.14 Billion
Shanghai RAAS Blood Products Co Ltd Class A (002252)	$170.01 Million	48.10%	0.80x	$4.52 Billion
Baolingbao Biology Co Ltd (002286)	$238.05 Million	18.81%	2.12x	$496.75 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287)	$2.26 Billion	16.10%	0.32x	$1.64 Billion

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.03 Billion

CN¥7.06 Billion CNY

Market Cap Rank

#8927 Global

#2249 in China

Share Price

CN¥17.06

Change (1 day)

+4.22%

52-Week Range

CN¥16.37 - CN¥34.72

All Time High

CN¥71.90